Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 10/20 | 0.52 |
| ▸ | TSHR | P16473 | 8/20 | 0.52 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | CD44 | P16070 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.34 |
| ▸ | IKBKB | O14920 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27728046 | 0.83 | CD44 (0.54) | ALDH1A1CYP3A4TSHRPIK3CATP53 | |
| SCHEMBL29384787 | 0.82 | CYP3A4 (0.62) | ALDH1A1CYP3A4TSHRPIK3CATP53 | |
| SCHEMBL6681654 | 0.82 | ALDH1A1 (0.48) | ALDH1A1CYP3A4TSHRPIK3CATP53 | |
| SCHEMBL33944 | 0.82 | CYP3A4 (0.62) | ALDH1A1CYP3A4TSHRPIK3CATP53 | |
| SCHEMBL30181379 | 0.81 | ALDH1A1 (0.52) | ALDH1A1CYP3A4TSHRPIK3CATP53 | |
| SCHEMBL8282372 | 0.81 | ALDH1A1 (0.52) | ALDH1A1CYP3A4TSHRPIK3CATP53 | |
| SCHEMBL3871698 | 0.81 | ALDH1A1 (0.52) | ALDH1A1CYP3A4TSHRPIK3CATP53 | |
| SCHEMBL2906897 | 0.81 | ALDH1A1 (0.52) | ALDH1A1CYP3A4TSHRPIK3CATP53 | |
| SCHEMBL2361143 | 0.81 | ALDH1A1 (0.52) | ALDH1A1CYP3A4TSHRPIK3CATP53 | |
| Hydrochloric Acid SCHEMBL21879618 | 0.79 | ALDH1A1 (0.50) | ALDH1A1CYP3A4TSHRPIK3CATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11655248-B2 | Pyridone-pyrimidine derivative acting as KRAS G12C mutein inhibitor | MEDSHINE DISCOVERY INC. (CN) | 2023-05-23 | — | — | US | disclosed |
| EP-3507275-B1 | CXCR3 RECEPTOR AGONISTS | RECEPTOS LLC (US) | 2023-04-26 | — | — | EP | disclosed |
| US-20230119573-A1 | GAS SEPARATION MEMBRANE, GAS SEPARATION MODULE, GAS SEPARATION APPARATUS, AND POLYIMIDE COMPOUND | FUJIFILM CORPORATION (JP) | 2023-04-20 | — | — | US | disclosed |
| CN-107974485-A | Ammonia quantitative approach, quantification kit, testing piece and ammonia proportioning device | 爱科来株式会社 | 2018-05-01 | — | — | CN | disclosed |
| CN-101665570-B | Method for synthesizing low-chloride polyphenylene sulfide resin | DEYANG KEJI HI TECH MATERIAL CO LTD | 2011-09-14 | — | — | CN | disclosed |
| CN-101665570-A | Method for synthesizing low-chloride polyphenylene sulfide resin | DEYANG KEJI HI TECH MATERIAL C | 2010-03-10 | — | — | CN | disclosed |
| EP-2046559-A2 | DUAL CURE ADHESIVE FORMULATIONS | LORD CORPORATION (US) | 2009-04-15 | — | — | EP | disclosed |
| WO-2008014466-A2 | DUAL CURE ADHESIVE FORMULATIONS | LORD CORPORATION (US) | 2008-01-31 | — | — | WO | disclosed |
| EP-0252603-A2 | Adhesives for ceramics and processes for the bonding of ceramics using same | MITSUI SEKIYU KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1988-01-13 | — | — | EP | disclosed |
| EP-0238672-A1 | PROCESS FOR DEOXIDIZING ALCOHOL | Yamasa Shoyu Kabushiki Kaisha (JP) | 1987-09-30 | — | — | EP | disclosed |
| EP-0034945-B1 | N-PHENYLPYRAZOLE DERIVATIVES | MAY & BAKER LIMITED (GB) | 1985-08-07 | — | — | EP | disclosed |
| US-4496390-A | WEED-CONTRTOLLING HERBICIDES | MAY & BAKER LIMITED (GB) | 1985-01-29 | — | — | US | disclosed |
| EP-0034945-A2 | N-phenylpyrazole derivatives | MAY & BAKER LIMITED (GB) | 1981-09-02 | — | — | EP | disclosed |
| US-4148799-A | Process for the preparation of 2-aryliminothiazoline solutions | BAYER AKTIENGESELLSCHAFT (DE) | 1979-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11655248-B2 | Pyridone-pyrimidine derivative acting as KRAS G12C mutein inhibitor | KRAS, NRAS, MSH2 | ALDH1A1 2032/4885CYP3A4 3267/4885TSHR 4157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.